Page last updated: 2024-11-04

sulfasalazine and Hepatitis C

sulfasalazine has been researched along with Hepatitis C in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitoro, A1
Yoshikawa, M1
Yamamoto, K1
Mimura, M1
Yoshikawa, Y1
Shiroi, A1
Mochi, T1
Sakamoto, T1
Yamao, J1
Kikuchi, E1

Other Studies

1 other study available for sulfasalazine and Hepatitis C

ArticleYear
Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C.
    Internal medicine (Tokyo, Japan), 1993, Volume: 32, Issue:4

    Topics: Adult; Autoimmune Diseases; Chronic Disease; Colitis, Ulcerative; Hepatitis C; Humans; Interferon Ty

1993